The University of Southampton
University of Southampton Institutional Repository

Novel insights into the genomic architecture of Chronic Lymphocytic Leukaemia

Novel insights into the genomic architecture of Chronic Lymphocytic Leukaemia
Novel insights into the genomic architecture of Chronic Lymphocytic Leukaemia
Sequential karyotypic and FISH analysis in patients with CLL show evidence of genomic evolution in 10 – 20% of cases. In addition, telomere dysfunction has been shown to correlate with genomic instability and thus may be involved in genomic evolution. Since specific deletions have been found to be associated with different disease prognosis, the acquisition of secondary aberrations may impact on disease progression. To investigate this, DNA samples of 29 patients presenting with either stage A0 CLL or mBL were analysed at two different time points, PT and FU (median time between sample: 85 months. Patients were grouped as either stable (for 5 or more years) or progressive (treated within 3 years). High resolution Affymetrix SNP6.0 array was used to investigate copy number aberrations and loss of heterozygosity at both time points and FISH/karyotype data was used for confirmation and validation.. In addition, the high resolution STELA technique was used to measure telomere length at each time point. It was found that patients with progressive as well as stable disease had acquired secondary aberrations at FU, including novel deletions and gains. Telomere loss was also found in both groups of patients. 11q/17p aberrations and large (>2Mb) but not small (<2Mb) 13q deletion (P=0.03) were associated with genomic evolution and telomere loss. Several established biomarkers, including IgVH mutational status shown not such correlation. A number of patients identified as good risk at diagnosis, acquired adverse genomic features at follow-up. These included the acquisition of a class II 13q deletion and a complex genomic profile. Finally, case studies enabled a more detailed analysis and revealed the presence of secondary aberrations in conjunction with sudden shifts in WBC count that are a marker of disease progression. This study supports the need to detect genomic changes throughout the course of the disease, and genomic aberrations can be acquired and effect prognosis.
Rajabali, Miqdad
79c2ebd2-f6b8-4322-a4bb-c8144198f657
Rajabali, Miqdad
79c2ebd2-f6b8-4322-a4bb-c8144198f657
Strefford, Jon
3782b392-f080-42bf-bdca-8aa5d6ca532f
Sahota, Surinder
66c1457f-cba2-4c49-9c8c-fcee0748b6b8

Rajabali, Miqdad (2011) Novel insights into the genomic architecture of Chronic Lymphocytic Leukaemia. University of Southampton, Faculty of Medicine, Masters Thesis, 210pp.

Record type: Thesis (Masters)

Abstract

Sequential karyotypic and FISH analysis in patients with CLL show evidence of genomic evolution in 10 – 20% of cases. In addition, telomere dysfunction has been shown to correlate with genomic instability and thus may be involved in genomic evolution. Since specific deletions have been found to be associated with different disease prognosis, the acquisition of secondary aberrations may impact on disease progression. To investigate this, DNA samples of 29 patients presenting with either stage A0 CLL or mBL were analysed at two different time points, PT and FU (median time between sample: 85 months. Patients were grouped as either stable (for 5 or more years) or progressive (treated within 3 years). High resolution Affymetrix SNP6.0 array was used to investigate copy number aberrations and loss of heterozygosity at both time points and FISH/karyotype data was used for confirmation and validation.. In addition, the high resolution STELA technique was used to measure telomere length at each time point. It was found that patients with progressive as well as stable disease had acquired secondary aberrations at FU, including novel deletions and gains. Telomere loss was also found in both groups of patients. 11q/17p aberrations and large (>2Mb) but not small (<2Mb) 13q deletion (P=0.03) were associated with genomic evolution and telomere loss. Several established biomarkers, including IgVH mutational status shown not such correlation. A number of patients identified as good risk at diagnosis, acquired adverse genomic features at follow-up. These included the acquisition of a class II 13q deletion and a complex genomic profile. Finally, case studies enabled a more detailed analysis and revealed the presence of secondary aberrations in conjunction with sudden shifts in WBC count that are a marker of disease progression. This study supports the need to detect genomic changes throughout the course of the disease, and genomic aberrations can be acquired and effect prognosis.

PDF
Miqdad Rajabali MPhil Thesis 2011.pdf - Other
Download (11MB)

More information

Published date: June 2011
Organisations: University of Southampton, Cancer Sciences

Identifiers

Local EPrints ID: 372951
URI: http://eprints.soton.ac.uk/id/eprint/372951
PURE UUID: bca788c4-56a3-4bbe-ab6a-b68c4a0cef32
ORCID for Jon Strefford: ORCID iD orcid.org/0000-0002-0972-2881

Catalogue record

Date deposited: 19 Jan 2015 14:51
Last modified: 06 Jun 2018 12:43

Export record

Contributors

Author: Miqdad Rajabali
Thesis advisor: Jon Strefford ORCID iD
Thesis advisor: Surinder Sahota

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×